Today: 29 April 2026
Browse Category

NYSE:TMO 31 July 2025 - 4 December 2025

Thermo Fisher Scientific (TMO) Stock on December 2, 2025: Price Action, HSBC Upgrade, New Debt Deal and 2026–2030 Forecasts

Thermo Fisher Scientific (TMO) Stock on December 2, 2025: Price Action, HSBC Upgrade, New Debt Deal and 2026–2030 Forecasts

Thermo Fisher Scientific shares traded near $580 midday Tuesday, down less than 1% but close to their 52-week high of $611. HSBC raised its price target on the stock to $670. The company recently announced a €2.1 billion bond sale and a $5 billion share repurchase plan. An insider filed to sell 6,912 shares valued at about $4 million.
2 December 2025
··
Thermo Fisher Scientific (TMO) Stock on 1 December 2025: HSBC Upgrade, Insider Moves, Buyback and 2026–2030 Forecasts

Thermo Fisher Scientific (TMO) Stock on 1 December 2025: HSBC Upgrade, Insider Moves, Buyback and 2026–2030 Forecasts

Thermo Fisher Scientific shares traded at $584–585 on December 1, 2025, with a market cap near $223 billion and a P/E ratio of 34.2. HSBC upgraded the stock to “Buy” the same day, citing improved prospects. Boston Family Office increased its stake by 3% in Q2, while First National Advisers cut its position by 59%. Institutional investors hold about 89% of the float.
1 December 2025
··
Thermo Fisher Scientific (TMO) Stock News Today: Insider Selling, Institutional Buying and New Growth Moves – November 28, 2025

Thermo Fisher Scientific (TMO) Stock News Today: Insider Selling, Institutional Buying and New Growth Moves – November 28, 2025

Thermo Fisher Scientific traded near $590.83 per share late Friday, with a market cap of about $222 billion. Institutional investors, including Global Retirement Partners and Laurel Wealth Advisors, disclosed new or increased stakes. An executive vice president sold $6.43 million in shares. The stock remains near its 52-week high of just over $610.
29 November 2025
·
Thermo Fisher (TMO) Stock Surges on Biotech Boom – Analysts Eye $650 Target

Thermo Fisher (TMO) Stock Surges on Biotech Boom – Analysts Eye $650 Target

Thermo Fisher (TMO) closed at $558.07 on Oct 21, up 2.6% for the day and over 11% in October, rebounding from a 10% year-over-year dip. The company has spent $2 billion on U.S. operations and announced a $4.1 billion deal for Solventum’s filtration business. Q3 results are due Oct 22, with analysts expecting EPS of ~$5.50 and revenue near $10.91 billion. JP Morgan raised its 12-month price target to $650.
21 October 2025
·
Market Record Rally Amid Shutdown: A Deep Dive into U.S. Stock Performance on 1 October 2025

Market Record Rally Amid Shutdown: A Deep Dive into U.S. Stock Performance on 1 October 2025

U.S. stocks closed at record highs despite a partial government shutdown, with the S&P 500 up 0.34% to 6,711.20 and the Dow rising 0.09% to 46,441.10. Health-care shares jumped after Pfizer and the White House struck a drug price deal, sending Biogen up 10.9%. The ADP report showed private-sector jobs fell by 32,000 in September, but investors bet on Fed rate cuts.
1 October 2025
·····
Beyond the Eyepiece: The Next-Gen Microscopes of 2025–2026 Revolutionizing How We See the World

Beyond the Eyepiece: The Next-Gen Microscopes of 2025–2026 Revolutionizing How We See the World

Zeiss launched Lightfield 4D in March 2025, enabling instant volumetric imaging in LSM 910/990 microscopes at up to 80 stacks per second, with Microscopy Copilot AI. Nikon released the Eclipse Ti2-I in July 2025 for IVF clinics, consolidating controls and reducing workflow steps by up to 75%. Leica’s Visoria series debuted in May 2025 with tablet-based viewing and automatic metadata encoding.
31 July 2025
····
1 2 3 4

Stock Market Today

  • Smart Share Global Withdraws ADS Listing from Nasdaq
    April 29, 2026, 1:50 PM EDT. Smart Share Global Ltd has formally withdrawn its American Depositary Shares (ADS) listing from the Nasdaq Stock Market. The move was confirmed through the filing of Form 25 with the U.S. Securities and Exchange Commission, which notifies the removal of a security from exchange listing and registration. Nasdaq executed the delisting based on regulatory compliance provisions under the Securities Exchange Act of 1934. Smart Share Global, headquartered in Shanghai, China, did not disclose detailed reasons behind the withdrawal. This development marks a significant shift for the Chinese firm's market presence in the United States, raising questions about future listing strategies or market focus.

Latest article

Sagtec Global Stock Jumps After Record 2025 Revenue, but Costs Tell a Harder Story

Sagtec Global Stock Jumps After Record 2025 Revenue, but Costs Tell a Harder Story

29 April 2026
Sagtec Global reported 2025 audited revenue of $19.1 million, up 49%, driven by strong growth in services. Shares surged 38% to $2.35 in U.S. trading after volatile swings. Operating income dropped 9% to $2.1 million and earnings per share fell to $0.09 from $0.16, reflecting higher costs after the Nasdaq IPO. Net cash from operations rose 187% to $4.1 million.
Dow Jones Today: Why the Blue-Chip Index Is Sliding Before Powell, Big Tech and the Oil Shock

Dow Jones Today: Why the Blue-Chip Index Is Sliding Before Powell, Big Tech and the Oil Shock

29 April 2026
The Dow Jones Industrial Average dropped 320 points, or 0.65%, to 48,821.82 Wednesday afternoon, heading for a fifth straight loss as investors awaited the Federal Reserve’s rate decision and major tech earnings. Brent crude surged 7.14% to $119.20 after reports of a possible extended Iran blockade. Boeing and Goldman Sachs weighed on the Dow, while Amazon rose and Microsoft slipped in midday trading.
Go toTop